NCQM — National Committee for Quality Management

Search NCQM

Federal regulation

Medical Devices: Quality Management System Regulation

The Quality Management System Regulation is the current FDA device CGMP framework, effective February 2, 2026. Part 820 incorporates ISO 13485:2016 by reference with FDA-specific provisions and definitions. Manufacturers must consider the complete regulatory framework rather than treating a third-party ISO certificate as an FDA approval. FDA also changed its device inspection approach when QMSR became effective.

Reference
21 CFR Part 820; ISO 13485:2016 incorporated by reference
Source authority
Food and Drug Administration
Legal character
Part 820 is binding within its scope and incorporates specified ISO material; ISO certification alone does not establish FDA compliance.

Current framework and covered manufacturers

QMSR became effective on February 2, 2026. FDA describes its application to finished-device manufacturers intending commercial distribution, subject to the regulation’s provisions and applicable exemptions. A finished device includes an accessory suitable for use or capable of functioning, even before packaging, labeling or sterilization. Determine the manufacturing role and product classification before evaluating individual requirements. FDA QMSR overview.

Incorporation with FDA requirements

Part 820 incorporates ISO 13485:2016 and specified definitions from ISO 9000:2015. The incorporated edition is the one identified in the regulation; a later ISO revision does not automatically amend federal law. FDA-specific terminology and supplemental requirements must be read alongside the incorporated material. This brief does not reproduce the privately copyrighted standard. Part 820.

Quality management across the device lifecycle

The system needs to connect the activities applicable to the device, including supplier and production controls, appropriate design responsibilities, complaint handling and improvement processes. Scope depends on the actual role and exemptions. An inherited quality manual should be assessed against the current requirements and operating evidence rather than renamed and presumed adequate. FDA QMSR resources.

Inspection records and earlier evidence

FDA’s QMSR questions explain that investigators may review relevant records created before the effective date. The former exceptions from routine inspection for management review and quality or supplier audit reports are not retained in QMSR. Comparative analysis can help explain how earlier records support present requirements without fabricating new historical documentation. FDA inspection questions.

Certification and the broader FDA framework

FDA does not require or issue an ISO 13485 certificate to establish QMSR compliance, and such a certificate does not replace FDA inspection. Other device duties, including applicable premarket authorization, medical device reporting, corrections and removals, and labeling, remain separate. A certificate’s scope must not be presented as an FDA endorsement of a product. FDA QMSR questions.

Access and implementation review

Obtain authorized access to the incorporated standards, identify applicable FDA additions, and map the combined obligations to actual procedures and records. FDA links read-only access information for the incorporated material. Use the current inspection resources when planning a review; the former QSIT approach was discontinued when QMSR took effect. Access and inspection information.

Official sources

Sources checked 2026-10-19. This is the review date for this profile, separate from any legal effective or compliance date.

  1. codified regulation

    21 CFR Part 820

    www.ecfr.gov

  2. agency explanation

    Quality Management System Regulation

    www.fda.gov

  3. agency explanation

    QMSR Frequently Asked Questions

    www.fda.gov

How these profiles are prepared · Request a correction

Practice guidance